Pohlan, Julian
Möckel, Martin
Slagman, Anna
Tenenbaum, Hannah
Stolz, Jules
Rubarth, Kerstin
Winning, Johannes
Bauer, Michael
Reinhart, Konrad
Stacke, Angelika
Dewey, Marc
Bolanaki, Myrto http://orcid.org/0000-0003-2032-8559
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung
Charité - Universitätsmedizin Berlin
Article History
Received: 31 October 2023
Revised: 25 January 2024
Accepted: 17 February 2024
First Online: 9 April 2024
Declarations
:
: The scientific guarantor of this publication is Myrto Bolanaki.
: M.B. declares funds from the Federal Ministry of Research and Education, Roche Diagnostics, and ThermoFisher BRAHMS. M.M. reports research funds from the Federal Ministry of Research and Education (Bundesministerium für Bildung und Forschung), the Innovation Fonds (Gemeinsamer Bundesausschuss), Roche Diagnostics, and consulting fees and speakers’ honoraria from Roche Diagnostics, ThermoFisher BRAHMS, Abbott, Medtronic, and Radiometer. A.S. reports research funds from the German Research Council (Deutsche Forschungsgemeinschaft), the Federal Ministry of Research and Education (Bundesministerium für Bildung und Forschung), the Innovation Fonds (Gemeinsamer Bundesausschuss), Roche Diagnostics, and ThermoFisher BRAHMS. J.W., M.B., and A.S. report grants from the Federal Ministry of Research and Education (Bundesministerium für Bildung und Forschung). K.R. reported research grants from the Innovation Fonds (Gemeinsamer Bundesausschuss) and holds shares of the InflaRx NV, Jena Germany.M.B. participated in advisory boards of Brahms/Thermofisher regarding the use of biomarkers to diagnose sepsis. The remaining authors declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
: One of the authors, K.R., has significant statistical expertise.
: Written informed consent was obtained from all subjects (patients) or their legal representatives in this study.
: Institutional Review Board approval was obtained by the ethical committee of the participating clinic (Charité Berlin) and was registered under DRKS00011188 according to the German Registry of clinical trials.
: Some study subjects or cohorts have been previously reported in our published article “Diagnostic Performance of Procalcitonin for the Early Identification of Sepsis in Patients with Elevated qSOFA Score at Emergency Admission.” Bolanaki M, Möckel M, Winning J, Bauer M, Reinhart K, Stacke A, Hajdu P, Slagman A. J Clin Med. 2021 Aug 28;10(17):3869. ExternalRef removed. PMID: 34501324; PMCID: PMC8432218.
: UnorderedList removed